ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 210

Changes in Alcohol Use in Patients with Rheumatoid Arthritis: Associations with Disease Activity, Health Status, and Mortality

Joshua Baker1, Harlan Sayles2, Bryant R. England3, Ted R. Mikuls4 and Kaleb Michaud5, 1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3Rheumatology, VA Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, 4Internal Medicine, Division of Rheumatology, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 5Rheumatology, University of Nebraska Medical Center, Omaha, NE

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: alcohol use, death and rheumatoid arthritis (RA), Disease Activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Prior studies observed better disease control, quality of life, and physical function among patients with rheumatoid arthritis (RA) who drink alcohol. These studies may suffer from reverse causality due to discontinuation of use over time among those with poor health. We assessed factors associated with changes in alcohol use over time and the effects of discontinuation on disease activity and mortality in a large RA registry.

Methods: RA participants in FORWARD, the National Databank for Rheumatic Diseases, were asked about alcohol use on semi-annual surveys (any v. none). Our disease activity measure was the Patient Activity Scale 2 (PAS2). Logistic regression models with generalized estimating equations assessed associations between patient factors and alcohol use at the time of the next questionnaire among those reporting current regular alcohol intake. Multivariable logistic regression and Cox proportional hazards models illustrated survival of alcohol use over time by disease activity categories and assessed the risk of discontinuation of alcohol use on subsequent worsening of disease activity (>0.5 standard deviation change) and mortality.

Results: In 121,280 observations (16,722 unique patients), alcohol users had lower PAS2 [β: -0.18 (-0.21, -0.15) p<0.001]. Discontinuation of alcohol was common among drinkers (8.2% of observations). Higher disease activity was associated with future discontinuation of alcohol (Table, Figure). This was explained by other factors associated with discontinuation: older age, female sex, non-white race, obesity, comorbidity, work disability, low educational level and income, and poor physical/mental quality of life. Recent discontinuation (in prior 6 month interval) was not independently associated with a subsequent increase in PAS2 over the subsequent 6 months after adjustment [OR 1.03 (0.94, 1.13) p=0.58]. Discontinuation was associated with a greater risk of death [HR 1.58 (1.25, 2.00) p<0.001], but not independently of the above factors [HR 1.13 (0.86, 1.47) p=0.36]. Sensitivity analyses limited only to moderate alcohol use were similar.

Conclusion: Higher disease activity, disability, comorbidity, and poor quality of life are associated with discontinuation of alcohol use in RA. Discontinuation of alcohol is not independently associated with worsening disease activity or greater mortality. These observations highlight a need to ensure that a behavioral exposure temporally precedes the outcome in epidemiologic studies and calls into question previously described benefits of alcohol consumption in RA.

Table: Associations between disease activity and discontinuation of alcohol use.

Model 1

Odds of Discontinuation

(N=7,937; Obs=52,345)

Model 2

Odds of Discontinuation

(N=7,817; Obs=51,073)

OR (95% CI)

p

OR  (95% CI)

p

Age  <50

Reference

Reference

Age 50-60

1.02 (0.92, 1.13)

0.71

1.01 (0.90, 1.12)

0.90

Age 60-70

1.08 (0.97, 1.20)

0.18

1.04 (0.93, 1.16)

0.13

Age 70-80

1.22 (1.09, 1.37)

0.001

1.12 (0.98, 1.27)

0.002

Age  >80

1.54 (1.32, 1.80)

<0.001

1.27 (1.08, 1.51)

0.005

Male

0.69 (0.61, 0.77)

<0.001

0.72 (0.64, 0.81)

<0.001

White

0.69 (0.58, 0.82)

<0.001

0.73 (0.62, 0.87)

<0.001

BMI

  Low

1.04 (0.73, 1.49)

0.81

1.03 (0.71, 1.50)

0.86

  Normal

Reference

Reference

  Overweight

1.10 (0.98, 1.23)

0.16

1.04 (0.93, 1.17)

0.47

  Obese

1.57 (1.41, 1.75)

<0.001

1.37 (1.22, 1.54)

<0.001

Methotrexate

1.04 (0.97, 1.12)

0.28

1.05 (0.97, 1.13)

0.21

Prednisone

1.10 (1.03, 1.19)

0.008

1.06 (0.98, 1.14)

0.16

Any Biologic

0.92 (0.86, 0.99)

0.02

0.94 (0.87, 1.01)

0.08

PAS2

  Remission

Reference

Reference

  Low

1.36 (1.27, 1.44)

<0.001

1.07 (1.00, 1.15)

0.06

  Mod-High

1.85 (1.37, 2.51)

<0.001

1.22 (0.90, 1.66)

0.19

Work Disability

—

—

1.18 (1.06, 1.32)

0.003

RDCI

—

—

1.02 (1.00, 1.04)

0.02

Liver Disease

—

—

1.23 (0.99, 1.53)

0.07

Physical QOL

—

—

0.99 (0.98, 0.99)

<0.001

Mental QOL

—

—

0.99 (0.99,1.00)

0.001

Education ³16 yrs

—

—

0.84 (0.76, 0.93)

0.001

Income (Ref 0-25K)

—

—

Reference

—

   35-55K

—

—

0.84 (0.77, 0.92)

<0.001

   65-150K

—

—

0.72 (0.65, 0.79)

<0.001


Disclosure: J. Baker, Corrona, LLC, 5; H. Sayles, None; B. R. England, None; T. R. Mikuls, BMS, Ironwood, Horizon, 2,Pfizer, Inc., 5; K. Michaud, None.

To cite this abstract in AMA style:

Baker J, Sayles H, England BR, Mikuls TR, Michaud K. Changes in Alcohol Use in Patients with Rheumatoid Arthritis: Associations with Disease Activity, Health Status, and Mortality [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/changes-in-alcohol-use-in-patients-with-rheumatoid-arthritis-associations-with-disease-activity-health-status-and-mortality/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/changes-in-alcohol-use-in-patients-with-rheumatoid-arthritis-associations-with-disease-activity-health-status-and-mortality/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology